Analysts See $-0.09 EPS for AxoGen, Inc. (AXGN); 0 Bullish Analysts Covering Southside Bancshares, Inc. (SBSI)

February 16, 2018 - By Adrian Erickson

Among 5 analysts covering Southside Bancshares (NASDAQ:SBSI), 0 have Buy rating, 0 Sell and 5 Hold. Therefore 0 are positive. Southside Bancshares had 10 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Southside Bancshares, Inc. (NASDAQ:SBSI) has “Hold” rating given on Friday, October 27 by Piper Jaffray. The rating was maintained by Piper Jaffray on Tuesday, February 6 with “Hold”. The firm earned “Hold” rating on Tuesday, October 3 by Keefe Bruyette & Woods. The firm has “Hold” rating given on Monday, August 28 by Keefe Bruyette & Woods. The firm has “Hold” rating by Keefe Bruyette & Woods given on Thursday, December 21. The company was maintained on Thursday, June 1 by Keefe Bruyette & Woods. The company was initiated on Friday, September 22 by Piper Jaffray. See Southside Bancshares, Inc. (NASDAQ:SBSI) latest ratings:

06/02/2018 Broker: Piper Jaffray Rating: Hold New Target: $38.0 Maintain
21/12/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $38.0 Maintain
27/10/2017 Broker: Piper Jaffray Rating: Hold New Target: $37.0 Maintain
03/10/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $37.0 Maintain
22/09/2017 Broker: PiperJaffray Rating: Neutral New Target: $37 Initiates Coverage On
22/09/2017 Broker: Piper Jaffray Rating: Hold New Target: $37.0 Initiate
28/08/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $38.0 Maintain

Analysts expect AxoGen, Inc. (NASDAQ:AXGN) to report $-0.09 EPS on February, 28.They anticipate $0.01 EPS change or 10.00% from last quarter’s $-0.1 EPS. After having $-0.06 EPS previously, AxoGen, Inc.’s analysts see 50.00% EPS growth. The stock increased 1.86% or $0.5 during the last trading session, reaching $27.4. About 265,230 shares traded. AxoGen, Inc. (NASDAQ:AXGN) has risen 181.49% since February 16, 2017 and is uptrending. It has outperformed by 164.79% the S&P500.

Southside Bancshares, Inc. operates as a bank holding firm for Southside Bank that provides a range of financial services to individuals, businesses, municipal entities, and nonprofit organizations. The company has market cap of $1.21 billion. The Company’s deposit products include savings, money market, and interest and noninterest bearing checking accounts, as well as certificates of deposit. It has a 19.09 P/E ratio. The companyÂ’s loan portfolio comprises consumer loans that include 1-4 family residential loans, home equity loans, home improvement loans, automobile loans, and other installment loans; commercial loans, such as short-term working capital loans for inventory and accounts receivable, short and medium-term loans for equipment or other business capital expansion, commercial real estate loans, and municipal loans; and construction loans for 1-4 family residential and commercial real estate.

Investors sentiment decreased to 1.63 in Q3 2017. Its down 0.45, from 2.08 in 2017Q2. It dropped, as 7 investors sold Southside Bancshares, Inc. shares while 28 reduced holdings. 7 funds opened positions while 50 raised stakes. 14.40 million shares or 0.51% less from 14.48 million shares in 2017Q2 were reported. Mason Street Advsrs Lc stated it has 6,987 shares. State Of Alaska Department Of Revenue has invested 0.01% of its portfolio in Southside Bancshares, Inc. (NASDAQ:SBSI). Guggenheim Limited Liability stated it has 0% in Southside Bancshares, Inc. (NASDAQ:SBSI). First Bank & Trust Of Omaha has invested 0.12% in Southside Bancshares, Inc. (NASDAQ:SBSI). National Bank & Trust Of New York Mellon Corp owns 0.01% invested in Southside Bancshares, Inc. (NASDAQ:SBSI) for 560,806 shares. Glenmede Com Na holds 0% of its portfolio in Southside Bancshares, Inc. (NASDAQ:SBSI) for 1,626 shares. Pub Sector Pension Investment Board stated it has 17,242 shares. 22,768 are held by Sei Investments. Barclays Public Lc has invested 0% in Southside Bancshares, Inc. (NASDAQ:SBSI). State Board Of Administration Of Florida Retirement Sys stated it has 24,659 shares or 0% of all its holdings. California State Teachers Retirement Systems holds 0% of its portfolio in Southside Bancshares, Inc. (NASDAQ:SBSI) for 44,515 shares. Bnp Paribas Arbitrage Sa has 0% invested in Southside Bancshares, Inc. (NASDAQ:SBSI) for 15,534 shares. Moreover, Ubs Asset Mgmt Americas Inc has 0% invested in Southside Bancshares, Inc. (NASDAQ:SBSI). Comerica National Bank accumulated 0.01% or 29,410 shares. Swiss National Bank stated it has 46,718 shares or 0% of all its holdings.

Since September 14, 2017, it had 1 insider buy, and 2 insider sales for $40,444 activity. 1,500 Southside Bancshares, Inc. (NASDAQ:SBSI) shares with value of $49,500 were sold by MCCABE BRIAN K. Boyd Peter M sold 750 shares worth $26,394. MORGAN TONY K bought 1,000 shares worth $35,450.

The stock increased 0.32% or $0.11 during the last trading session, reaching $34.55. About 124,057 shares traded. Southside Bancshares, Inc. (NASDAQ:SBSI) has risen 21.44% since February 16, 2017 and is uptrending. It has outperformed by 4.74% the S&P500.

Among 8 analysts covering AxoGen (NASDAQ:AXGN), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. AxoGen had 18 analyst reports since August 11, 2015 according to SRatingsIntel. As per Thursday, November 2, the company rating was maintained by Leerink Swann. Lake Street upgraded it to “Buy” rating and $11 target in Tuesday, November 22 report. The stock has “Buy” rating by Cantor Fitzgerald on Monday, August 21. Lake Street downgraded AxoGen, Inc. (NASDAQ:AXGN) on Thursday, November 3 to “Hold” rating. As per Tuesday, August 11, the company rating was upgraded by Zacks. The company was maintained on Monday, September 11 by Roth Capital. On Friday, August 28 the stock rating was maintained by Wedbush with “Outperform”. Cantor Fitzgerald maintained AxoGen, Inc. (NASDAQ:AXGN) rating on Monday, January 8. Cantor Fitzgerald has “Buy” rating and $37.0 target. The rating was maintained by Leerink Swann with “Outperform” on Tuesday, November 21. As per Monday, November 7, the company rating was maintained by Wedbush.

AxoGen, Inc. provides surgical solutions for peripheral nerve injuries. The company has market cap of $934.17 million. The company's surgical nerve repair solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect injured peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. It currently has negative earnings. The Company’s solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that is used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: